zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
vinblastin-richter 5 mg proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań
gedeon richter plc. - vinblastini sulfas - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań - 5 mg
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - leki immunosupresyjne - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
endoxan 50 mg tabletki drażowane
baxter polska sp. z o.o. - cyclophosphamidum - tabletki drażowane - 50 mg
endoxan 200 mg proszek do sporządzania roztworu do wstrzykiwań
baxter polska sp. z o.o. - cyclophosphamidum - proszek do sporządzania roztworu do wstrzykiwań - 200 mg
endoxan 1000 mg proszek do sporządzania roztworu do wstrzykiwań
baxter polska sp. z o.o. - cyclophosphamidum - proszek do sporządzania roztworu do wstrzykiwań - 1000 mg
epanutin parenteral 50 mg/ml roztwór do wstrzykiwań
upjohn eesv - phenytoinum natricum - roztwór do wstrzykiwań - 50 mg/ml
holoxan 1 g proszek do sporządzania roztworu do wstrzykiwań
baxter polska sp. z o.o. - ifosfamidum - proszek do sporządzania roztworu do wstrzykiwań - 1 g
holoxan 2 g proszek do sporządzania roztworu do wstrzykiwań
baxter polska sp. z o.o. - ifosfamidum - proszek do sporządzania roztworu do wstrzykiwań - 2 g
holoxan 40 mg/ml roztwór do infuzji
baxter polska sp. z o.o. - ifosfamidum - roztwór do infuzji - 40 mg/ml